52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Completed

Conditions studied: Hypertension

In brief

52-104 week off-therapy second extension to study CSPP100A2365 to assess growth and development in pediatric hypertensive patients previously treated with aliskiren in studies SPP100A2365 and SPP100A2365E1

Key facts

Study ID

NCT01420068

Run by

Noden Pharma

People needed

106

Starts

2011-08-19

Expected to finish

2017-08-03

Last updated by the study team

2019-03-19

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Successful completion of study CSPP100A2365E1
• Patients must meet inclusion criteria set forth for trials CSPP100A2365 and CSPP100A2365E1
• Informed consent/ patient assent

You may not qualify if…

• Patients who did not successfully complete studies CSPP100A2365 and CSPP100A2365E1

Where it is running

• Novartis Investigative Site — Birmingham, Alabama, United States
• Novartis Investigative Site — Little Rock, Arkansas, United States
• Novartis Investigative Site — Dalton, Georgia, United States
• Novartis Investigative Site — Lewiston, Idaho, United States
• Novartis Investigative Site — Hattiesburg, Mississippi, United States
• Novartis Investigative Site — Jackson, Mississippi, United States
• Novartis Investigative Site — New York, New York, United States
• Novartis Investigative Site — Portland, Oregon, United States
• Novartis Investigative Site — Portland, Oregon, United States
• Novartis Investigative Site — Charleston, South Carolina, United States
• Novartis Investigative Site — Amarillo, Texas, United States
• Novartis Investigative Site — Guatemala City, Guatemala
• Novartis Investigative Site — Budapest, Hungary
• Novartis Investigative Site — Nyíregyháza, Hungary
• Novartis Investigative Site — Szeged, Hungary
• Novartis Investigative Site — Veszprém, Hungary
• Novartis Investigative Site — Warsaw, Poland
• Novartis Investigative Site — San Juan, Puerto Rico
• Novartis Investigative Site — Bratislava, Slovakia
• Novartis Investigative Site — Martin, Slovakia
• Novartis Investigative Site — Myjava, Slovakia
• Novartis Investigative Site — Prešov, Slovakia
• Novartis Investigative Site — Trnava, Slovakia
• Novartis Investigative Site — Ankara, Turkey (Türkiye)
• Novartis Investigative Site — Ankara, Turkey (Türkiye)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.